Benitec Biopharma Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +12.4% | +92.6% | -55.9% | +25.5% | +126.4% | -57.0% | +1,421.6% | +565.1% | -4.8% | -89.1% | +16.6% | -94.7% | +123.1% | -57.8% | -186.8% | – | -98.2% | +0.0% | +100.0% | +2.1% | +1,124.3% | +92.0% | -47.9% | +1,788.0% | -97.0% | +285.7% | -87.0% | -100.0% | – | – | -200.0% | – | – | – | – | -100.0% | – | – | – | – | |
| – | +294.3% | +112.3% | -113.5% | – | +295.5% | +43.1% | +112.6% | +3.1% | -4.2% | -83.0% | +1.5% | -10.0% | -1,225.3% | – | -38.0% | +179.2% | -114.2% | – | -85.7% | +10,100.0% | -100.0% | – | – | +1,033.3% | -59.8% | -22.0% | +162.5% | -226.2% | – | -400.0% | – | +506.7% | -11.0% | +30.9% | +162.3% | -57.6% | +1.7% | -0.8% | +4.2% | – | |
| – | -57.4% | +47.7% | +133.2% | -25.8% | +63.8% | -146.4% | – | – | -4.8% | -89.4% | +17.4% | -98.8% | +5,131.2% | -105.8% | – | – | – | -130.0% | – | -10,300.0% | – | +92.0% | -118.8% | – | – | +285.7% | -87.0% | +1,414.3% | -100.9% | – | -800.0% | – | – | – | – | -142.4% | – | – | – | – | |
| – | -53.0% | +28.7% | +9.8% | -11.4% | +30.3% | -20.7% | +9.3% | -15.6% | -78.8% | +835.0% | +10.6% | -65.2% | +35.4% | +55.9% | -31.7% | -14.6% | +50.9% | +136.1% | -15.9% | +19.8% | +13.2% | -31.0% | +46.3% | -16.2% | +41.4% | -15.8% | +0.6% | +39.0% | +15.2% | -49.7% | +36.9% | +2.1% | +50.2% | +20.6% | -43.1% | -8.8% | +73.1% | +8.0% | +52.7% | – | |
| – | -1.8% | +15.6% | -12.1% | +5.6% | -6.4% | -0.9% | -16.5% | -20.3% | +216.2% | -47.7% | -17.5% | -1.9% | +141.6% | -21.2% | -10.4% | -3.2% | +14.9% | -51.3% | +49.3% | +32.9% | -16.1% | -22.0% | +16.2% | +23.6% | -3.0% | -34.1% | +11.6% | +13.1% | +17.6% | -13.5% | +29.0% | +8.3% | +145.7% | +63.1% | +52.5% | -52.3% | +17.3% | -3.4% | -10.2% | – | |
| – | -19.9% | -7.3% | +7.5% | -2.3% | +8.7% | -101.4% | – | -69.7% | -116.0% | – | -4.5% | -42.7% | +103.3% | -2.7% | -18.8% | -6.7% | +25.6% | +15.5% | +1.8% | +25.1% | +0.8% | -27.8% | +34.8% | -3.2% | +22.8% | -21.9% | +3.7% | +31.2% | +15.8% | -40.2% | +33.9% | +2.7% | +88.1% | +42.0% | -36.2% | -0.7% | +37.4% | +1.6% | +6.3% | – | |
| – | – | – | – | – | – | – | – | – | -7.3% | -163.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -20.4% | +10,014.1% | -5.6% | -5.9% | +218.8% | -98.0% | +100.0% | +0.0% | -50.0% | +0.0% | +1,000.0% | -9.1% | +0.0% | -10.0% | +0.0% | -22.2% | +14.3% | -25.0% | +0.0% | -33.3% | – | – | +36.3% | +0.0% | +25.9% | -2.4% | +37.5% | – | – | – | |
| – | -548.2% | – | – | – | – | – | – | – | -26.1% | -171.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -98.9% | -154.9% | – | -33.0% | +53.9% | -99.2% | -21,727.5% | – | – | – | – | – | – | – | – | -32.9% | -94.5% | +3,766.7% | +27.6% | +50.7% | -95.1% | -1,781.8% | – | – | -138.8% | – | -214.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -863.8% | – | – | – | – | – | – | – | -26.1% | -171.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -443.8% | – | – | – | – | – | – | – | -6.3% | -161.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.